Soluble HER-2 in Patients with Head and Neck Squamous Cell Carcinoma

机译：头颈部鳞状细胞癌患者中的可溶性HER-2

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Introduction:The presence of HER-2 has been shown to be a prognostic factor in many kinds of cancers, but its role in head and neck squamous cell carcinoma (HNSCC) is not still defined. The purpose of the current study is to investigate the role of HER-2 in HNSCC and its correlation with various clinicopathologic parameters.

机译：简介：HER-2的存在已被证明是多种癌症的预后因素，但其在头颈部鳞状细胞癌（HNSCC）中的作用仍未明确。本研究的目的是调查HER-2在HNSCC中的作用及其与各种临床病理参数的相关性。

著录项

期刊名称 Iranian Journal of Otorhinolaryngology
作者
Bijan Khademi; Behzad Khademi; Abbas Ghaderi; Seyd Fakhroddin Hosseini; Nika Niknejad;
展开▼
作者单位

展开▼
年(卷),期 2013(25),72
年度 2013
页码 161–168
总页数 7
原文格式 PDF
正文语种
中图分类耳鼻喉科学;
关键词
入库时间 2022-08-17 12:00:33

相似文献

外文文献
中文文献
专利

1. Combined molecular targeted drug therapy for EGFR and HER-2 in head and neck squamous cell carcinoma cell lines [J] . Norio Kondo, Mamoru Tsukuda, Atsuko Sakakibara, International journal of oncology . 2012,第6期

机译：EGFR和HER-2分子靶向药物联合治疗头颈部鳞状细胞癌
2. Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites. [J] . Dahlstrom KR, Li G, Tortolero Luna G, Head and neck: Journal for the sciences and specialities of the head and neck . 2011,第6期

机译：口咽鳞状细胞癌患者与其他头颈部位鳞状细胞癌患者之间性行为史的差异。
3. Antitumor effects of lapatinib (GW572016), a dual inhibitor of EGFR and HER-2, in combination with cisplatin or paclitaxel on head and neck squamous cell carcinoma. [J] . Kondo N, Tsukuda M, Ishiguro Y, Oncology reports . 2010,第4期

机译：拉帕替尼（GW572016）是EGFR和HER-2的双重抑制剂，与顺铂或紫杉醇联用对头颈部鳞状细胞癌的抗肿瘤作用。
4. CCND1 as a Predictive Biomarker of Neoadjuvant Chemotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma [C] . Zhien Feng, Lizhen Wang, Bingshun Wang, Academic Committee Conference of Shanghai key lab of stomatology . 2011

机译：CCND1作为局部晚期头颈部鳞状细胞癌患者新辅助化疗的预测生物标志物
5. The prognostic potential of the epidermal growth factor receptor and nuclear factor kappa B pathways and associated therapeutic strategies in patients with squamous cell carcinoma of the head and neck. [D] . Wirth, Pamela Susan. 2010

机译：表皮生长因子受体和核因子κB通路对头颈部鳞状细胞癌患者的预后潜力及相关治疗策略。
6. Deletion of C9orf53 promotes the growth of head and neck squamous cell carcinoma and is associated with poor prognosis of patients with head and neck squamous cell carcinoma [O] . Guo Dong Wang, Jian Tao Huang, Yuan Liu, -1

机译：C9orf53的缺失促进头颈部鳞状细胞癌的生长并与头颈部鳞状细胞癌患者的预后不良有关
7. Squamous Cell Carcinoma in the Region of Respiratory and Digestive Organs. Cellular and Molecular Analyses. A Study of the Soluble Factors Derived from Human Squamous Cell Carcinoma of the Head and Neck Cell Lines. [O] . Hideki Hirabayashi 1995

机译：呼吸和消化器官区域的鳞状细胞癌。细胞和分子分析。头颈细胞系人鳞状细胞癌的可溶因子研究。

Soluble HER-2 in Patients with Head and Neck Squamous Cell Carcinoma

摘要

著录项

相似文献

相关主题

期刊订阅